Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988111985720
Publisher
SAGE Publications
Online
2019-07-15
DOI
10.1177/0269881119857204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic study of microdosing psychedelics
- (2019) Vince Polito et al. PLoS One
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
- (2019) Lindsay P. Cameron et al. ACS Chemical Neuroscience
- Psychedelic medicine: The biology underlying the persisting psychedelic effects
- (2019) K.P.C. Kuypers MEDICAL HYPOTHESES
- Motives and Side-Effects of Microdosing With Psychedelics Among Users
- (2019) Nadia R P W Hutten et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- DARK Classics in Chemical Neuroscience: Psilocybin
- (2018) Haden A. Geiger et al. ACS Chemical Neuroscience
- Psilocin and ketamine microdosing
- (2018) Rachel R. Horsley et al. BEHAVIOURAL PHARMACOLOGY
- Accelerated Development of the Dual Orexin Receptor Antagonist ACT-541468: Integration of a Microtracer in a First-in-Human Study
- (2018) Clemens Muehlan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Psychedelics: Where we are now, why we got here, what we must do
- (2018) Sean J. Belouin et al. NEUROPHARMACOLOGY
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
- (2018) Eduardo Ekman Schenberg Frontiers in Pharmacology
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
- (2018) Luisa Prochazkova et al. PSYCHOPHARMACOLOGY
- Serotonin and brain function: a tale of two receptors
- (2017) RL Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
- (2017) Candace R. Lewis et al. NEUROIMAGE
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Modern Clinical Research on LSD
- (2017) Matthias E Liechti NEUROPSYCHOPHARMACOLOGY
- Sleep homeostasis regulated by 5HT2b receptor in a small subset of neurons in the dorsal fan-shaped body of Drosophila
- (2017) Yongjun Qian et al. eLife
- The role of methysergide in migraine and cluster headache treatment worldwide – A survey in members of the International Headache Society
- (2016) E Anne MacGregor et al. CEPHALALGIA
- Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in huma
- (2016) Andrea E. Steuer et al. Drug Testing and Analysis
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
- (2016) Vincent Beliveau et al. JOURNAL OF NEUROSCIENCE
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
- (2016) Patrick C Dolder et al. NEUROPSYCHOPHARMACOLOGY
- The paradoxical psychological effects of lysergic acid diethylamide (LSD)
- (2016) R. L. Carhart-Harris et al. PSYCHOLOGICAL MEDICINE
- Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
- (2016) David A. Martin et al. EBioMedicine
- Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model
- (2015) Felix Nau et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
- (2015) Yasmin Schmid et al. BIOLOGICAL PSYCHIATRY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
- (2015) Flávia de L. Osório et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
- (2014) Tobias Buchborn et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
- (2014) David A. Martin et al. NEUROPHARMACOLOGY
- Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
- (2013) Felix Nau et al. PLoS One
- Distribution of 5-ht1E receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study
- (2012) MT Klein et al. BRITISH JOURNAL OF PHARMACOLOGY
- Co-Occurring Psychotic and Addictive Disorders
- (2012) Stephen Ross et al. CLINICAL NEUROPHARMACOLOGY
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
- (2011) Danuta Marona-Lewicka et al. NEUROPHARMACOLOGY
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Serotonin receptors and heart valve disease—It was meant 2B
- (2011) Joshua D. Hutcheson et al. PHARMACOLOGY & THERAPEUTICS
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Harm potential of magic mushroom use: A review
- (2011) Jan van Amsterdam et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
- (2010) Erich Studerus et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
- (2010) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- To scale or not to scale: the principles of dose extrapolation
- (2009) Vijay Sharma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
- (2009) Ouissame Mnie-Filali et al. CURRENT DRUG TARGETS
- 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice
- (2009) Alex Brenchat et al. PAIN
- Prodrug Approaches for CNS Delivery
- (2008) Jarkko Rautio et al. AAPS Journal
- The utility of microdosing over the past 5 years
- (2008) Graham Lappin et al. Expert Opinion on Drug Metabolism & Toxicology
- Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor- -Induced Inflammation with Extraordinary Potency
- (2008) B. Yu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effects of varied doses of psilocybin on time interval reproduction in human subjects
- (2008) Jiří Wackermann et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search